Washington, United States: It is for the time, that the Fungi will be sent to the International Space Station for the development of the medicine, as disclosed by the University of Southern California’s researchers.
It is also further revealed by the researchers that the joint experiments are to be conducted by the Scientists from the University and also by the Jet Propulsion Laboratory of NASA- National Aeronautics and Space Administration. Moreover, in the experiments, which will be putting specimen of Aspergillus nidulans in the high- radiationand micro- gravity condition in the space for developing new medicines for the use of the Space and on the Earth. The information are being given through the announcements made on Monday, by the University of Southern California.
Moreover, it is also disclosed that the specimen will be carried by the SpaceX CRS- 8 mission scheduled for the launch on 8th day of April, from Cape Canaveral. Also, the launch would be the first cargo resupply service mission of Hawthorne- based company, since CRS- 7 exploded shortly after launch as seen on 28th day of June, last year, as per reports of Xinhua.
Further, in statements, the University Southern California also stated that there are several types of the Fungi products very essential molecules which are called secondary metabolites, are not much important for their growth or reproduction, however, they can be taken for making pharmaceuticals, which are much beneficial. And as per researchers, the space’s environment could bring physiological changes in the Fungi produces.
It is clarified by saying that “the high- radiation, micro- gravity environment” in the space could “prompt” Aspergillus nidulans to produce molecules, which it cannot seemed creating on the Earth and it is having stressful conditions on earth. The statements were clarified by the professor of pharmacology and pharmaceutical sciences and chemistry at the University Southern California school of pharmacy- Clay Wang, in media.
Moreover, as per Wang, the researchers have done extensive genetic analysis of this fungus and “found that it could potentially produce 40 different types of drugs”. Further, as per researchers, the molecules from Aspergillus nidulans can potentially be used against cancer and Alzheimer’s disease research.